Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Mariana Cherner

    TitleAssociate Professor In Residence
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address200 W. Arbor Drive #8231
    CA San Diego 92103
    Phone619-543-5048
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Mariana Cherner is Associate Professor In Residence in the Department of Psychiatry at UCSD as well as a faculty member in the SDSU/UCSD Joint Doctoral Program in Clinical Psychology. She graduated with a BA in Psychology from Cornell University and obtained her Ph.D. at the SDSU/UCSD Joint Doctoral Program in Clinical Psychology, specializing in neuropsychology and behavioral medicine. She completed a clinical psychology internship at the University of Washington, where she also received postdoctoral training in neuropsychology. Dr. Cherner directs the Interdisciplinary Research Fellowship in NeuroAIDS (IRFN) and is an investigator within the HIV Neurobehavioral Research Center (HNRC) and the Translational Methamphetamine AIDS Research Center (TMARC). Her research is on neurobehavioral correlates of HIV and stimulant dependence, focusing on individual differences in vulnerability to methamphetamine-related brain dysfunction and HIV transmission risk behaviors. She is also interested in culturally competent neuropsychological assessment, with a focus on Spanish speakers and HIV in resource-limited settings.

      Biography

      Dr. Cherner is Associate Professor In Residence in the Department of Psychiatry at UCSD as well as a faculty member in the SDSU/UCSD Joint Doctoral Program in Clinical Psychology. She graduated with a BA in Psychology from Cornell University and obtained her Ph.D. at the SDSU/UCSD Joint Doctoral Program in Clinical Psychology, specializing in neuropsychology and behavioral medicine. She completed a clinical psychology internship at the University of Washington, where she also received postdoctoral training in neuropsychology. Dr. Cherner directs the Interdisciplinary Research Fellowship in NeuroAIDS (IRFN) and is an investigator within the HIV Neurobehavioral Research Center (HNRC) and the Translational Methamphetamine AIDS Research Center (TMARC). Her research is on neurobehavioral correlates of HIV and stimulant dependence, focusing on individual differences in vulnerability to methamphetamine-related brain dysfunction and HIV transmission risk behaviors. She is also interested in culturally competent neuropsychological assessment, with a focus on Spanish speakers and HIV in resource-limited settings.

      Research Interests

      Dr. Cherner has an interest in the role of coexisting conditions such as stimulant drug (methamphetamine, MDMA) abuse and hepatitis C in the manifestation of HIV-associated neurocognitive disorders. Her current work focuses on genetically determined individual differences in vulnerability to brain dysfunction among methamphetamine users with HIV. The other focus of her research is in the area of cross-cultural neuropsychology, with a special interest in international neuroAIDS research and culturally competent assessment of cognitive abilities in Spanish speakers. She conducts her work within the HIV Neurobehavioral Research Program, where she is an investigator on a number of federally funded projects. She also directs the Interdisciplinary Research Fellowship in NeuroAIDS and participates in training and mentorship of pre- and postdoctoral researchers.

      Clinical Focus

      Dr. Cherner is a licensed clinical psychologist trained in adult neuropsychological assessment, with expertise in cross-cultural neuropsychological evaluation as well as neurobehavioral consequences of infectious disease and substance misuse.


      Collapse Research 
      Collapse Research Activities and Funding
      Mentoring Clinical Researchers at the Intersection of NeuroAIDS and Substance Abuse
      NIH/NIDA K24DA040550Jul 1, 2015 - Jun 30, 2020
      Role: Principal Investigator
      Modeling Neural Injury Effects of Methamphetamine Metabolism by CYP2D6 in HIV
      NIH/NIDA R21DA036423Sep 15, 2013 - Aug 31, 2015
      Role: Principal Investigator
      CYP2D6 Genotype and Cognitive Deficits in Methamphetamine Users with/without HIV
      NIH/NIDA R01DA035736Apr 15, 2013 - Feb 29, 2016
      Role: Principal Investigator
      Genetics of Monooxygenase Activity &Methamphetamine-Related Brain Injury in HIV
      NIH/NIDA R03DA027513Sep 15, 2009 - Aug 31, 2012
      Role: Principal Investigator
      COMT Genotype and Risky Decision Making in HIV and Methamphetamine Dependence
      NIH/NIDA R01DA026334Aug 15, 2009 - Jul 31, 2012
      Role: Principal Investigator
      Interdisciplinary Research Fellowship in NeuroAIDS
      NIH/NIMH R25MH081482Aug 15, 2007 - May 31, 2022
      Role: Principal Investigator
      Functional &Cognitive Impact of HIV in Spanish Speakers
      NIH/NIMH R01MH064907Jan 1, 2004 - Dec 31, 2009
      Role: Principal Investigator
      Neurocognitive Consequences of MDMA Use in HIV
      NIH/NIMH R03MH064903Jun 1, 2002 - May 31, 2005
      Role: Principal Investigator
      ETHNIC DIFFERENCES IN PSYCHOSOCIAL VARIABLES IN HIV
      NIH/NIMH R03MH055903Mar 1, 1996 - Feb 28, 1997
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK. Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. J Int Neuropsychol Soc. 2017 Sep 06; 1-13. PMID: 28874213.
        View in: PubMed
      2. de Almeida SM, Kamat R, Cherner M, Umlauf A, Ribeiro CE, de Pereira AP, Franklin D, Heaton RK, Ellis RJ. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery. J Acquir Immune Defic Syndr. 2017 03 01; 74(3):332-338. PMID: 27828876.
        View in: PubMed
      3. Jumare J, Sunshine S, Ahmed H, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Umlauf A, Cherner M, Abimiku A, Charurat M, Li JZ, Blattner WA, Royal W. Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria. J Neurovirol. 2017 Jun; 23(3):474-482. PMID: 28243867.
        View in: PubMed
      4. Kanmogne GD, Qiu F, Ntone FE, Fonsah JY, Njamnshi DM, Kuate CT, Doh RF, Kengne AM, Tagny CT, Nchindap E, Kenmogne L, Mbanya D, Cherner M, Heaton RK, Njamnshi AK. Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender. PLoS One. 2017; 12(2):e0171956. PMID: 28231258.
        View in: PubMed
      5. Bharti AR, McCutchan A, Deutsch R, Smith DM, Ellis RJ, Cherner M, Woods SP, Heaton RK, Grant I, Letendre SL. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults. Clin Infect Dis. 2016 Dec 15; 63(12):1655-1660. PMID: 27794019.
        View in: PubMed
      6. de Almeida SM, Barbosa FJ, Kamat R, de Pereira AP, Raboni SM, Rotta I, Ribeiro CE, Cherner M, Ellis RJ, Atkinson JH. Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil. J Neurovirol. 2016 Dec; 22(6):789-798. PMID: 27431676.
        View in: PubMed
      7. Spies G, Fennema-Notestine C, Cherner M, Seedat S. Changes in cognitive function in women with HIV infection and early life stress. AIDS Care. 2017 Jan; 29(1):14-23. PMID: 27396980.
        View in: PubMed
      8. Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre SL. Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV AIDS (Auckl). 2016; 8:93-9. PMID: 27199571; PMCID: PMC4857802.
      9. Montoya JL, Cattie J, Morgan E, Woods SP, Cherner M, Moore DJ, Atkinson JH, Grant I. The impact of age, HIV serostatus and seroconversion on methamphetamine use. Am J Drug Alcohol Abuse. 2016 Mar; 42(2):168-77. PMID: 26837461; PMCID: PMC4842208 [Available on 03/01/17].
      10. Royal W, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria. PLoS One. 2016; 11(2):e0147182. PMID: 26829391; PMCID: PMC4734765.
      11. Pérez-Santiago J, Schrier RD, de Oliveira MF, Gianella S, Var SR, Day TR, Ramirez-Gaona M, Suben JD, Murrell B, Massanella M, Cherner M, Smith DM, Ellis RJ, Letendre SL, Mehta SR. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection. J Neurovirol. 2016 Apr; 22(2):191-200. PMID: 26428514; PMCID: PMC4862614 [Available on 04/01/17].
      12. Spies G, Ahmed-Leitao F, Fennema-Notestine C, Cherner M, Seedat S. Effects of HIV and childhood trauma on brain morphometry and neurocognitive function. J Neurovirol. 2016 Apr; 22(2):149-58. PMID: 26424107; PMCID: PMC4959545 [Available on 04/01/17].
      13. Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. J Neurovirol. 2014 Dec; 20(6):561-70. PMID: 25326107; PMCID: PMC4367960.
      14. Vahia IV, Ng B, Camacho A, Cardenas V, Cherner M, Depp CA, Palmer BW, Jeste DV, Agha Z. Telepsychiatry for Neurocognitive Testing in Older Rural Latino Adults. Am J Geriatr Psychiatry. 2015 Jul; 23(7):666-70. PMID: 25708655; PMCID: PMC4363076.
      15. Akolo C, Royal W, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neurovirol. 2014 Aug; 20(4):380-7. PMID: 24927825; PMCID: PMC4312476.
      16. Cañizares S, Cherner M, Ellis RJ. HIV and aging: effects on the central nervous system. Semin Neurol. 2014 Feb; 34(1):27-34. PMID: 24715486; PMCID: PMC4296735.
      17. Suarez PA, Gollan TH, Heaton R, Grant I, Cherner M. Second-language fluency predicts native language stroop effects: evidence from Spanish-English bilinguals. J Int Neuropsychol Soc. 2014 Mar; 20(3):342-8. PMID: 24622502; PMCID: PMC4296729.
      18. Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, McCutchan JA, Archibald SL, Miller DJ, Kesidis G, Cushman C, Kim SM, Abramson I, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Corkran S, Cherner M, Duarte NA, Alexander T, Robinson-Papp J, Gelman BB, Simpson DM, Collier AC, Marra CM, Morgello S, Brown G, Grant I, Atkinson JH, Jernigan TL, Ellis RJ. HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol. 2014 Jun; 20(3):209-18. PMID: 24549970; PMCID: PMC4040150.
      19. Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA. Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis. 2014 Apr; 58(7):1015-22. PMID: 24352352; PMCID: PMC3952601.
      20. de Almeida SM, Ribeiro CE, de Pereira AP, Badiee J, Cherner M, Smith D, Maich I, Raboni SM, Rotta I, Barbosa FJ, Heaton RK, Umlauf A, Ellis RJ. Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. J Neurovirol. 2013 Dec; 19(6):550-6. PMID: 24277437; PMCID: PMC3923762.
      21. Kamat R, Morgan E, Marcotte TD, Badiee J, Maich I, Cherner M, de Almeida S, de Pereira AP, Ribeiro CE, Barbosa F, Atkinson JH, Ellis R. Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil. J Affect Disord. 2013 Sep 25; 150(3):1069-75. PMID: 23245465; PMCID: PMC3619015.
      22. Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL. Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35. PMID: 23018443; PMCID: PMC3576852.
      23. Royal W, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, McCutchen JA, Grant I, Blattner WA. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol. 2012 Jun; 18(3):191-9. PMID: 22528480; PMCID: PMC3717366.
      24. Bousman CA, Salgado H, Hendrix T, Fraga M, Cherner M. Assessing neuropsychological performance in a migrant farm working Colonia in Baja California, Mexico: a feasibility study. J Immigr Minor Health. 2011 Aug; 13(4):742-7. PMID: 21264515; PMCID: PMC3132389.
      25. Gupta S, Bousman CA, Chana G, Cherner M, Heaton RK, Deutsch R, Ellis RJ, Grant I, Everall IP. Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings. J Neurovirol. 2011 Jun; 17(3):239-47. PMID: 21491142; PMCID: PMC3151555.
      26. Ances BM, Vaida F, Cherner M, Yeh MJ, Liang CL, Gardner C, Grant I, Ellis RJ, Buxton RB. HIV and chronic methamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011 Sep; 6(3):409-19. PMID: 21431471; PMCID: PMC3251315.
      27. Bousman CA, Cherner M, Emory KT, Barron D, Grebenstein P, Atkinson JH, Heaton RK, Grant I. Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning. J Int Neuropsychol Soc. 2010 Nov; 16(6):1047-55. PMID: 20735886; PMCID: PMC3737074.
      28. Cherner M, Bousman C, Everall I, Barron D, Letendre S, Vaida F, Atkinson JH, Heaton R, Grant I. Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc. 2010 Sep; 16(5):890-901. PMID: 20727252; PMCID: PMC3543816.
      29. Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 2010 Jul 30; 178(2):295-8. PMID: 20478633; PMCID: PMC2902702.
      30. Iudicello JE, Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK, Atkinson JH, Grant I. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. J Clin Exp Neuropsychol. 2010 Aug; 32(7):704-18. PMID: 20198527; PMCID: PMC2911490.
      31. Bousman CA, Cherner M, Glatt SJ, Atkinson JH, Grant I, Tsuang MT, Everall IP. Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine. Neurobehav HIV Med. 2010 Jan 01; 2010:1-11. PMID: 24078782.
        View in: PubMed
      32. Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):154-63. PMID: 19815352; PMCID: PMC2814900.
      33. Mitha K, Yirsalign M, Cherner M, McCutchan A, Langford TD. Risk perception and beliefs regarding HIV infection among Ethiopian immigrants. AIDS Educ Prev. 2009 Oct; 21(5):484-94. PMID: 19842831.
        View in: PubMed
      34. Hightower GK, Letendre SL, Cherner M, Gibson SA, Ellis RJ, Wolfson TJ, Gamst AC, Ignacio CC, Heaton RK, Grant I, Richman DD, Smith DM. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance. Virology. 2009 Nov 25; 394(2):243-8. PMID: 19762060; PMCID: PMC3046809.
      35. Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol. 2009 Apr; 15(2):131-8. PMID: 19115126; PMCID: PMC3979854.
      36. Cherner M, Suarez P, Posada C, Fortuny LA, Marcotte T, Grant I, Heaton R. Equivalency of Spanish language versions of the trail making test part B including or excluding "CH". Clin Neuropsychol. 2008 Jul; 22(4):662-5. PMID: 17853122; PMCID: PMC3059802.
      37. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis. 2007 Aug 01; 196(3):361-70. PMID: 17597450.
        View in: PubMed
      38. Cherner M, Suarez P, Lazzaretto D, Fortuny LA, Mindt MR, Dawes S, Marcotte T, Grant I, Heaton R. Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol. 2007 Mar; 22(3):343-53. PMID: 17293078; PMCID: PMC3737073.
      39. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol. 2007; 13(1):23-8. PMID: 17454445.
        View in: PubMed
      40. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006 Apr 04; 20(6):879-87. PMID: 16549972.
        View in: PubMed
      41. Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005 Oct; 19 Suppl 3:S72-8. PMID: 16251831.
        View in: PubMed
      42. Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology. 2005 Apr 26; 64(8):1343-7. PMID: 15851720.
        View in: PubMed
      43. Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL, Cherner M, Heaton RK, Grant I. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology. 2005 Jan; 19(1):35-43. PMID: 15656761.
        View in: PubMed
      44. Gonzalez R, Rippeth JD, Carey CL, Heaton RK, Moore DJ, Schweinsburg BC, Cherner M, Grant I. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend. 2004 Nov 11; 76(2):181-90. PMID: 15488342.
        View in: PubMed
      45. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004 Sep; 26(6):759-78. PMID: 15370374.
        View in: PubMed
      46. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003 Dec 15; 188(12):1820-6. PMID: 14673760.
        View in: PubMed
      47. Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RK. The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol. 2003 Jun; 25(4):571-85. PMID: 12911108.
        View in: PubMed
      48. Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003 Feb; 25(1):122-32. PMID: 12607177; PMCID: PMC3737066.
      49. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003 Jan; 9(1):64-71. PMID: 12570359.
        View in: PubMed
      50. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002 Nov 26; 59(10):1563-7. PMID: 12451198.
        View in: PubMed
      Mariana's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _